LD50=537 mg/kg (Orally in rats). Signs of overdose include respiratory depression, muscle weakness, somnolence (general depressed activity).
An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Chlordiazepoxide. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Chlordiazepoxide. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chlordiazepoxide. |
| Hydrocodone | Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Chlordiazepoxide. |
| Magnesium sulfate | The therapeutic efficacy of Chlordiazepoxide can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Chlordiazepoxide may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Chlordiazepoxide. |
| Mirtazapine | Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Chlordiazepoxide. |
| Orphenadrine | Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Chlordiazepoxide. |
| Pramipexole | Chlordiazepoxide may increase the sedative activities of Pramipexole. |
| Ropinirole | Chlordiazepoxide may increase the sedative activities of Ropinirole. |
| Rotigotine | Chlordiazepoxide may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Chlordiazepoxide. |
| Suvorexant | Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Chlordiazepoxide. |
| Thalidomide | Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Clozapine | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Clozapine. |
| Methadone | Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Methadone. |
| Sodium oxybate | Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Teduglutide | The serum concentration of Chlordiazepoxide can be increased when it is combined with Teduglutide. |
| Yohimbine | The therapeutic efficacy of Chlordiazepoxide can be increased when used in combination with Yohimbine. |
| Ethanol | Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Chlordiazepoxide. |
| Zimelidine | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Dapoxetine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Seproxetine. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Escitalopram. |
| Milnacipran | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Desvenlafaxine. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Levomilnacipran. |
| Indalpine | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Alaproclate. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Chlordiazepoxide. |
| Propiomazine | The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Propiomazine. |
| Zopiclone | The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Zopiclone. |
| Caffeine | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Caffeine. |
| Dyphylline | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Dyphylline. |
| Pentoxifylline | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Pentoxifylline. |
| Mercaptopurine | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Mercaptopurine. |
| Oxtriphylline | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Oxtriphylline. |
| Theobromine | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Theobromine. |
| Fenethylline | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Fenethylline. |
| 8-azaguanine | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with 8-azaguanine. |
| 7,9-Dimethylguanine | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with 7,9-Dimethylguanine. |
| Xanthine | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Xanthine. |
| 7-Deazaguanine | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with 7-Deazaguanine. |
| Guanine | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Guanine. |
| 9-Methylguanine | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with 9-Methylguanine. |
| Peldesine | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Peldesine. |
| Hypoxanthine | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Hypoxanthine. |
| 9-Deazaguanine | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with 9-Deazaguanine. |
| Propentofylline | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Propentofylline. |
| Valomaciclovir | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Valomaciclovir. |
| 3-isobutyl-1-methyl-7H-xanthine | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with 3-isobutyl-1-methyl-7H-xanthine. |
| Uric acid | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Uric acid. |
| Doxofylline | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Doxofylline. |
| 6-O-benzylguanine | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with 6-O-benzylguanine. |
| Lisofylline | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Lisofylline. |
| Lobucavir | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Lobucavir. |
| Cafedrine | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Cafedrine. |
| Theodrenaline | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Theodrenaline. |
| Bamifylline | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Bamifylline. |
| Proxyphylline | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Proxyphylline. |
| Acefylline | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Acefylline. |
| Etamiphylline | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Etamiphylline. |
| Pentifylline | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Pentifylline. |
| Bufylline | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Bufylline. |
| Bromotheophylline | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Bromotheophylline. |
| Furafylline | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Furafylline. |
| 8-chlorotheophylline | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with 8-chlorotheophylline. |
| PCS-499 | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with PCS-499. |
| Theophylline | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Theophylline. |
| Aminophylline | The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Aminophylline. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Chlordiazepoxide. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Chlordiazepoxide. |
| Baclofen | Baclofen may increase the central nervous system depressant (CNS depressant) activities of Chlordiazepoxide. |
| Ethchlorvynol | The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Chlordiazepoxide. |
| Succinylcholine | The risk or severity of CNS depression can be increased when Succinylcholine is combined with Chlordiazepoxide. |
| Enflurane | The risk or severity of CNS depression can be increased when Enflurane is combined with Chlordiazepoxide. |
| Butabarbital | The risk or severity of CNS depression can be increased when Butabarbital is combined with Chlordiazepoxide. |
| Butalbital | The risk or severity of CNS depression can be increased when Butalbital is combined with Chlordiazepoxide. |
| Cabergoline | The risk or severity of CNS depression can be increased when Cabergoline is combined with Chlordiazepoxide. |
| Topiramate | The risk or severity of CNS depression can be increased when Topiramate is combined with Chlordiazepoxide. |